Johnson & Johnson (JNJ) announced that John Morikis, retired Chairman, President and Chief Executive Officer of The Sherwin-Williams Company (SHW), has been elected to its Board of Directors. “We are pleased to welcome John to our Company’s Board of Directors,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. “He is a proven leader of a large multinational organization who possesses a strong understanding of global markets and complex supply chains. His unique perspective and ability to harness technology to drive innovation will be an incredible asset to Johnson & Johnson as we continue to deliver the next generation of healthcare innovation for patients.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Johnson & Johnson announces new analyses from Phase 3 MARIPOSA study
- Nvidia, J&J, JPMorgan, McDonald’s, Roku: Major Stock Sales Unveiled
- Johnson & Johnson put volume heavy and directionally bearish
- RFK Jr. to claim autism link to Tylenol use in pregnancy, WSJ reports
- Balanced Outlook on Johnson & Johnson’s MedTech Growth Amid Competitive Challenges